|Articles|April 14, 2016
CRF Health Selected to Support Large Recorded COPD Trial
Advertisement
CRF Health's TrialMax platform has been selected to support a large Phase III study in COPD. The platform will be used to improve efficiency and increase patient-reported outcomes compliance for its 19,000 clinical trial patients. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
